Strength
150 mg/1
Manufacturer
AvPAKNDC
50268044115
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
IRBESARTANApproval Type
Generic (ANDA)
FDA Application
ANDA202910On Market Since
8/8/2023
Pharmacological Classes
Price Statistics
The NADAC for IRBESARTAN 150 MG TABLET has been published 260 times since Nov 15, 2017, and over the history we have for it it has declined 31.0%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1111 per EA |
|---|---|
| All-time high | $0.3249 (Oct 16, 2019) |
| All-time low | $0.0990 (Nov 20, 2024) |
| 52-week high | $0.1237 |
| 52-week low | $0.1103 |
| Median price | $0.1328 |
| Average price | $0.1603 |
| Largest weekly change | -50.3% (Feb 28, 2024) |
| Weeks tracked | 260 |
| Tracking since | Nov 15, 2017 |
Generic Alternatives
The matcher finds 5 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 5 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of IRBESARTAN 150 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for IRBESARTAN 150 MG TABLET, manufactured by AvPAK, is $0.1111 per EA (NDC 50268044115), effective Jun 24, 2026.
How has the price of IRBESARTAN 150 MG TABLET changed over time?
Over the history we have for it, the NADAC for IRBESARTAN 150 MG TABLET has declined 31.0%. It has been tracked across 260 weekly CMS publications since Nov 15, 2017.
What are the highest and lowest recorded NADAC prices for IRBESARTAN 150 MG TABLET?
Since Nov 15, 2017, the NADAC for IRBESARTAN 150 MG TABLET has ranged from a low of $0.0990 (Nov 20, 2024) to a high of $0.3249 (Oct 16, 2019), with a median of $0.1328 per EA.
Are there cheaper alternatives to IRBESARTAN 150 MG TABLET?
5 NADAC-published products share the same active ingredient, strength, and dosage form as IRBESARTAN 150 MG TABLET, but none are currently priced below it.
Who manufactures IRBESARTAN 150 MG TABLET?
IRBESARTAN 150 MG TABLET (NDC 50268044115) is labeled by AvPAK, and CMS classifies it as a generic product.
Related Drugs
Same classification